Source: United States & Canada – South China Morning PostUS health authorities have suspended the licence for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events”, the drug’s French maker said on Monday.
Ixchiq is one of just two vaccines approved by the US Food and Drug Administration (FDA) for the mosquito-spread virus, which mainly occurs in tropical and subtropical regions but has recently been discovered in countries worldwide.
French company Valneva obtained US approval for the vaccine in 2023, but…Read More